← Back to headlines
BioNxt Provides Update on Sublingual Drug Delivery Pipeline
BioNxt has issued an update on the development, intellectual property, and commercial progress of its sublingual drug delivery pipeline, detailing advancements in its pharmaceutical projects.
17 Aug, 10:40 — 17 Aug, 10:40
Related Stories
Anthropic and Nvidia-Backed Lambda Finalize $35 Billion Cloud Deal
1h ago
Global Outage Disrupts Microsoft Outlook Email Services
1h ago
Cathie Wood's ARK Invest Buys $53M in Nvidia, Sells Palantir and Buys Rocket Lab and Block
1h ago
FTC and 22 States Sue Amazon Over Alleged Ad Pricing Manipulation
2h ago